NCT00261092View on ClinicalTrials.gov

GEMOX: Oxaliplatin in Pancreatic Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

October 31, 2005

Conditions

Pancreatic Neoplasms

Interventions

DRUG

Oxaliplatin

Trial Locations (1)

Unknown

Sanofi-Aventis, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY